BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  iCAD Reports Financial Results for the Quarter Ended September 30, 2021

  iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three and nine months ended September 30, 2021.

  November 9, 2021

   · 

  23 min read
• Business

  ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights

  ChemoCentryx, Inc., (Nasdaq: CCXI), today announced financial results for the third quarter ended September 30, 2021 and provided an overview of recent corporate highlights.

  November 9, 2021

   · 

  15 min read
• Business

  Seer Reports Third Quarter 2021 Financial Results Customers demonstrate novel methods using the Proteograph Product Suite and continued commercial momentum ahead of Broad Release in early 2022

  Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, reported financial results for the third quarter ended September 30, 2021.

  November 9, 2021

   · 

  7 min read
• Business

  Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights

  Calithera Biosciences, Inc., a clinical-stage, precision oncology biopharmaceutical company, announced its financial results for the third quarter ended September 30, 2021.

  November 9, 2021

   · 

  8 min read
• Biotech Bay

  Harpoon Therapeutics to Participate in Two Upcoming Virtual Investor Conferences - Nov 09, 2021

  Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced that management will participate in two upcoming virtual investor conferences.

  November 9, 2021

   · 

  2 min read
• Alkermes to Take Part in the Stifel Virtual Healthcare Conference

  Alkermes plc announced that management will participate in a fireside chat at the Stifel Virtual Healthcare Conference on Tuesday, Nov. 16, 2021 at 9:20 a.m. ET.

  November 9, 2021

   · 

  1 min read
• Business

  Sera Prognostics Reports Third Quarter 2021 Financial Results

  Sera Prognostics Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced financial results for the third quarter ended September 30, 2021.

  November 9, 2021

   · 

  10 min read
• Business

  INOVIO Reports Third Quarter 2021 Financial Results

  INOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat people with cancer, and HPV-associated diseases, reported financial results for the quarter ended September 30, 2021.

  November 9, 2021

   · 

  20 min read
• Business

  Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings Guidance

  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2021 and updated financial guidance for 2021.

  November 9, 2021

   · 

  40 min read
• Business

  Kezar Reports Third Quarter 2021 Financial Results and Provides Business Update

  Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported financial results for the third quarter ended September 30, 2021 and provided a business update.

  November 9, 2021

   · 

  12 min read